News
5don MSN
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
4d
GlobalData on MSNExact Sciences expands partnership with Humana to improve colorectal cancer screeningThe Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...
Cologuard is easy for patients to use and easy for doctors to interpret the results, said Dr. Casey Allen, a surgical oncologist at Allegheny Health Network in Pennsylvania.
There are two reasons that I think the Cologuard is still a reasonable choice, despite the fact that it isn’t as good as colonoscopy. The first is that I continue to recommend a screening test for ...
Cologuard’s role: Where the colorectal cancer test fits in GI after FDA approval Earlier this month, the FDA approved Cologuard, the noninvasive stool DNA screening test for colorectal cancer from ...
Unlock URL Order Reprints Gift this Article An image from Cologuard's television ad By Teddy Nykiel – Reporter, Milwaukee Business Journal Mar 2, 2022 Updated Mar 3, 2022 10:26am CST ...
The Cologuard cancer screening test developed by Exact Sciences Corp. of Madison has won the highly regarded Prix Galien USA award for medical technology, Exact Sciences said Friday.
Cologuard measures DNA methylation in two genes: NDRG4 and BMP3. Abnormal methylation of NDRG4 and BMP3, considered tumor suppressors, has been linked to colorectal tumors.
Outside of those patients, Cologuard will own its addressable market and be rapidly adopted by physicians. Eventual penetration into the 70% range of this market is reasonable, and even at $300 ...
The Cologuard can say that you have an abnormality when a colonoscopy would indicate normal. For 45% of people with a positive Cologuard test, no abnormalities will be found upon colonoscopy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results